BamSEC and AlphaSense Join Forces
Learn More

Vyant Bio Inc

Formerly OTC: VYNT
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.7
from 10-K 3 pages Description of Vyant Bio Inc.’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.7
from 10-K 4 pages Description of Vyant Bio Inc.’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 14 pages Common Stock Purchase Warrant Vyant Bio, Inc
12/34/56
EX-4.14
from 10-K 4 pages Description of Cancer Genetics Inc.’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 19 pages Placement Agent Common Stock Purchase Warrant Cancer Genetics, Inc
12/34/56
EX-4.3
from 8-K 17 pages Placement Agent Common Stock Purchase Warrant Cancer Genetics, Inc. Warrant Shares: Issue Date: February 1, 2021 Initial Exercise Date: February 1, 2021
12/34/56
EX-4.1
from 8-K 17 pages Common Stock Purchase Warrant Cancer Genetics, Inc
12/34/56
EX-4.1
from 8-K 19 pages Common Stock Purchase Warrant Cancer Genetics, Inc
12/34/56
EX-4.1
from 425 19 pages Common Stock Purchase Warrant Cancer Genetics, Inc
12/34/56
EX-4.6
from S-3 59 pages Cancer Genetics, Inc., as Issuer and ● , as Trustee Indenture Dated as of ● Subordinated Debt Securities Cross Reference Sheet1 Between
12/34/56
EX-4.5
from S-3 56 pages Cancer Genetics, Inc., as Issuer and ● , as Trustee Indenture Dated as of ● Senior Debt Securities Cross Reference Sheet1 Between
12/34/56
EX-4.14
from 10-K 4 pages Description of Cancer Genetics Inc.’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 6 pages Promissory Note
12/34/56
EX-4.1
from 8-K 9 pages Subordinated Seller Note
12/34/56
EX-4.1
from 8-K 20 pages Common Stock Purchase Warrant Cancer Genetics, Inc
12/34/56
EX-4.1
from 8-K 22 pages Common Stock Purchase Warrant Cancer Genetics, Inc
12/34/56
EX-4.1
from 8-K 16 pages Convertible Promissory Note
12/34/56
EX-4.1
from 8-K 4 pages Cancer Genetics, Inc. Omnibus Warrant Amendment
12/34/56
EX-4.1
from 8-K 17 pages Common Stock Purchase Warrant Cancer Genetics, Inc
12/34/56
EX-4.1
from 8-K 13 pages Registration Rights Agreement
12/34/56